Acutaas Chemical

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE00FF01025
  • NSEID: ACUTAAS
  • BSEID: 543349
INR
1,881.45
68.45 (3.78%)
BSENSE

Feb 02

BSE+NSE Vol: 3.94 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Net Sales
906.61
698.39
492.51
430.35
376.59
247.72
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
906.61
698.39
492.51
430.35
376.59
247.72
Raw Material Cost
411.27
405.26
305.74
241.26
205.61
131.44
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-9.76
-15.56
-29.05
-15.45
-13.59
1.18
Employee Cost
84.29
60.36
46.07
37.35
30.40
15.55
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
-0.01
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
123.94
101.22
84.42
85.34
74.79
43.29
Total Expenditure (Excl Depreciation)
609.74
551.28
407.18
348.50
297.20
191.47
Operating Profit (PBDIT) excl Other Income
296.87
147.11
85.33
81.85
79.39
56.25
Other Income
30.48
11.15
6.14
4.49
2.59
2.05
Operating Profit (PBDIT)
327.35
158.26
91.47
86.34
81.98
58.30
Interest
2.08
5.62
3.87
1.82
5.82
4.20
Exceptional Items
0.00
0.00
-31.75
0.00
0.00
0.00
Gross Profit (PBDT)
325.27
152.64
55.85
84.52
76.16
54.10
Depreciation
26.35
19.32
11.16
8.92
6.97
3.00
Profit Before Tax
298.93
133.32
44.69
75.60
69.19
51.08
Tax
76.84
35.63
21.67
19.42
18.53
12.48
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
222.09
97.71
23.03
56.18
50.67
38.60
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
222.09
97.71
23.03
56.18
50.67
38.60
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-1.07
-0.49
-3.29
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
224.49
96.23
17.62
56.18
50.67
38.60
Equity Capital
40.94
40.93
36.88
36.44
36.44
10.50
Face Value
5.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
13.1
5.67
4.83
6.28
5.69
4.59
Operating Profit Margin (Excl OI)
32.75%
21.06%
17.33%
19.02%
21.08%
22.71%
Gross Profit Margin
35.88%
21.86%
11.34%
19.64%
20.22%
21.84%
PAT Margin
24.5%
13.99%
4.68%
13.05%
13.45%
15.58%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 29.81% vs 41.80% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in nine months ended Dec 2025 is 133.28% vs 446.14% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 101.80% vs 72.40% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is -62.99% vs 45.22% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024

Compare Nine Monthly Results Of Acutaas Chemical With
Markets Mojo
Figures in Cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
906.61
0
906.61
Other Operating Income
0.00
0.00
0.00
Total Operating income
906.61
0
906.61
Raw Material Cost
411.27
0
411.27
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
-9.76
0
-9.76
Employee Cost
84.29
0
84.29
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
123.94
0.00
123.94
Total Expenditure (Excl Depreciation)
609.74
0
609.74
Operating Profit (PBDIT) excl Other Income
296.87
0.00
296.87
Other Income
30.48
0
30.48
Operating Profit (PBDIT)
327.35
0
327.35
Interest
2.08
0
2.08
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
325.27
0
325.27
Depreciation
26.35
0
26.35
Profit Before Tax
298.93
0
298.93
Tax
76.84
0
76.84
Provisions and contingencies
0.00
0
0.00
Profit After Tax
222.09
0
222.09
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
222.09
0
222.09
Share in Profit of Associates
0.00
0
0.00
Minority Interest
-1.07
0
-1.07
Other related items
0.00
0.00
0.00
Consolidated Net Profit
224.49
0
224.49
Equity Capital
40.94
0
40.94
Face Value
5.00
0
0.00
Reserves
0.00
0
0.00
Gross Profit Margin
35.88%
0.00%
0.00
35.88%
PAT Margin
24.50%
0.00%
0.00
24.50%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 906.61 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 29.81% vs 41.80% in Dec 2024

Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 224.49 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 133.28% vs 446.14% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 296.87 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 101.80% vs 72.40% in Dec 2024

Nine Monthly - Interest
Interest 2.08 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -62.99% vs 45.22% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 32.75%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024